PATENT CLAIM ANALYSIS

Application Number: 15767361
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "017400"]

Abstract:
Methods for treating learning disabilities associated with fetal alcohol syndrome and other neurological disorders by administering SK channel blockers, antagonists, inhibitors or modifiers like tamapin.

Claim (Index 14):
The method of  claim 12 , wherein the subject has neurofibromatosis, Angelman syndrome or another neurological disease, disorder or condition other than dementia.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 91.0
- Lexical Diversity: 1.03704
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15543514', '15042976', '15124304', '15580419', '10807414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7467585910641739
- 35 USC 102 Novelty (BERT): 0.4963465936598821
- Combined Prediction Score: 0.7217173913237447
- Mean Citation Score: 161.699814
- Max Citation Score: 166.45508
- Similarity Product: 102.36801054620744

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test